Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (JPRN-jRCT1071250079) titled 'Efficacy of low-dose mirogabalin in hemodialysis patients' on Sept. 30.
Study Type: Interventional
Study Design:
single arm study, open(masking not used), uncontrolled control, single assignment, treatment purpose
Primary Sponsor: Kitamura Mineaki
Condition:
Neuralgia
neuropathic pain, hemodialysis
D009437
Intervention:
Hemodialysis patients
Mirogabalin tablets 2.5mg will be taken for 12 weeks.
Control patients
No intervention...
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 29/09/2025
Target Sample Size: 25
To know more, visit https://jrct.mhlw.go.jp/latest-detail/jRCT1...